FDA Drug Application (202419) for DIVALPROEX SODIUM by AUROBINDO PHARMA LTD

Back to FDA Applications sponsored by AUROBINDO PHARMA LTD

Application Number202419
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
DosageEQ 250MG VALPROIC ACID
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDIVALPROEX SODIUM
Active IngredientDIVALPROEX SODIUM



Back to FDA Applications sponsored by AUROBINDO PHARMA LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.